BiotechTube
Home/ImmunoScape/Tan Kar Wai, PhD
TK

Tan Kar Wai, PhD

Vice President, Discovery and Preclinical Sciences

ImmunoScape

Therapeutic Areas

Oncology

ImmunoScape Pipeline

DrugIndicationPhase
IS-001WT1‑positive solid tumorsPhase 1
CUE-102WT1‑positive tumors (booster)Phase 1

Leadership Team at ImmunoScape

MF
Michael Fehlings, PhD
Chief Executive Officer
RC
Romi Chandiramani, CA
Chief Financial Officer
AN
Alessandra Nardin, DVM
Vice President, Strategy
AB
Andrian Bot, MD/PhD
Chief Scientific Officer
View full ImmunoScape profile